Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
infectious diseases
immunotherapy mRNA therapeutics |
| gptkbp:foundedBy |
gptkb:BioNTech_SE
|
| https://www.w3.org/2000/01/rdf-schema#label |
BioNTech US Inc.
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:location |
gptkb:Cambridge,_Massachusetts
|
| gptkbp:parentCompany |
gptkb:BioNTech_SE
|
| gptkbp:product |
gptkb:COVID-19_vaccine_(BNT162b2,_with_Pfizer)
|
| gptkbp:subsidiary |
gptkb:BioNTech_SE
|
| gptkbp:bfsParent |
gptkb:BioNTech
|
| gptkbp:bfsLayer |
5
|